Neupedix (Alprostadil)

Alprostadil is a synthetic prostaglandin E1 analog that activates prostaglandin receptors on smooth‑muscle cells, raising intracellular cyclic AMP levels. The increase in cAMP causes smooth‑muscle relaxation, leading to vasodilation and inhibition of platelet aggregation, which underlies its therapeutic effects.

The dose of Neupedix is determined by the prescribing clinician based on the specific indication, patient characteristics, and clinical response. No fixed regimen is provided here; healthcare professionals set the appropriate dosage and infusion rate for each individual case.

Safety data for alprostadil during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Neupedix product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and any necessary import documentation.

For erectile dysfunction, the most common alternative is the phosphodiesterase‑5 inhibitor class (e.g., sildenafil). Alprostadil acts directly on vascular smooth muscle, whereas PDE5 inhibitors enhance nitric‑oxide signaling. In neonatal patent ductus arteriosus, indomethacin or ibuprofen are alternative prostaglandin‑synthesis inhibitors; alprostadil works by promoting ductal constriction rather than inhibiting prostaglandin production.

Neupedix should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability and potency.

Neupedix is administered by intravenous infusion under the supervision of a qualified healthcare professional. The prescribing clinician determines the infusion rate and total dose, and the medication is delivered through a sterile IV line according to standard aseptic techniques.

The most serious adverse events include priapism (a prolonged erection lasting more than four hours), severe hypotension that can lead to syncope, and systemic allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these occur.

Neupedix is contraindicated in patients with known hypersensitivity to alprostadil or other prostaglandin E1 analogs, in individuals with severe hypotension, and in those with certain cardiovascular conditions where vasodilation could be hazardous. A healthcare professional should assess suitability before initiating therapy.